Patents by Inventor Denise Wolf

Denise Wolf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BREAST CANCER-RESPONSE PREDICTION SUBTYPES
    Publication number: 20240060138
    Abstract: The disclosure describes a tumor subtyping schema for selection of therapies to treat Stage II and Stage III breast cancers.
    Type: Application
    Filed: February 24, 2023
    Publication date: February 22, 2024
    Inventors: Laura J. van't Veer, Denise Wolf, Christina Yau, Laura Esserman
  • MODULATION OF STIMULATORY AND NON-STIMULATORY MYELOID CELLS
    Publication number: 20220411496
    Abstract: Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
    Type: Application
    Filed: April 5, 2022
    Publication date: December 29, 2022
    Applicant: The Regents of the University of California
    Inventors: Matthew Krummel, Miranda Broz, Denise Wolf, Joshua Pollack, Mikhail Binnewies
  • Modulation of stimulatory and non-stimulatory myeloid cells
    Patent number: 11325973
    Abstract: Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: May 10, 2022
    Assignee: The Regents of the University of California
    Inventors: Matthew Krummel, Miranda Broz, Denise Wolf, Joshua Pollack, Mikhail Binnewies
  • Modulation of Stimulatory and Non-stimulatory Myeloid Cells
    Publication number: 20200017584
    Abstract: Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
    Type: Application
    Filed: July 1, 2019
    Publication date: January 16, 2020
    Applicant: The Regents of the University of California
    Inventors: Matthew Krummel, Miranda Broz, Denise Wolf, Joshua Pollack, Mikhail Biennewies
  • Modulation of stimulatory and non-stimulatory myeloid cells
    Patent number: 10428143
    Abstract: Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: October 1, 2019
    Assignee: The Regents of the University of California
    Inventors: Matthew Krummel, Miranda Broz, Denise Wolf, Joshua Pollack, Mikhail Biennewies
  • MODULATION OF STIMULATORY AND NON-STIMULATORY MYELOID CELLS
    Publication number: 20170291946
    Abstract: Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
    Type: Application
    Filed: September 28, 2015
    Publication date: October 12, 2017
    Applicant: The Regents of the University of California
    Inventors: Matthew Krummel, Miranda Broz, Denise Wolf, Joshua Pollack, Mikhail Biennewies